Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/12/2000 | CA2366799A1 Propofol compositions containing preservative additives |
10/12/2000 | CA2366791A1 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant |
10/12/2000 | CA2366787A1 Compositions and methods for treating lymphoma |
10/12/2000 | CA2365460A1 Fluorinated copolymers for coating biomedical devices and a process for their manufacture |
10/12/2000 | CA2363942A1 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites |
10/12/2000 | CA2361885A1 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
10/12/2000 | CA2333156A1 Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
10/12/2000 | CA2303702A1 Growth hormone and growth hormone releasing hormone compositions |
10/11/2000 | EP1043031A1 Sustained release medicinal compositions |
10/11/2000 | EP1043030A1 Sustained release medicinal compositions |
10/11/2000 | EP1043025A2 Renal cell carcinoma treatment |
10/11/2000 | EP1043023A1 Viscous compositions containing carbon dioxide |
10/11/2000 | EP1043020A1 Medicinal composition for percutaneous administration |
10/11/2000 | EP1043018A1 Magnetic field effect patch |
10/11/2000 | EP1043016A1 A plant extract based on glycerides, a method for the preparation of this extract and a cosmetic composition containing the same |
10/11/2000 | EP1042460A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
10/11/2000 | EP1042405A1 Gelatine compositions |
10/11/2000 | EP1042388A1 Polyhydroxyalkanoate compositions having controlled degradation rates |
10/11/2000 | EP1042339A2 Carbohydrates, useful in solid delivery systems |
10/11/2000 | EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
10/11/2000 | EP1042100A1 Laser beam cutting method for cutting laminates for applying to the skin |
10/11/2000 | EP1042007A2 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |
10/11/2000 | EP1042004A1 Method for tissue perfusion |
10/11/2000 | EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
10/11/2000 | EP1042002A1 Pharmaceutical formulations and processes for their preparation |
10/11/2000 | EP1042001A1 Use of microparticles combined with submicron oil-in-water emulsions |
10/11/2000 | EP1041998A1 Composition and method for dermal and transdermal administration of a cytokine |
10/11/2000 | EP1041996A1 Keratinocyte growth factor-2 formulations |
10/11/2000 | EP1041993A1 Ophthalmic compositions and process of using |
10/11/2000 | EP1041992A1 Hyperhydrated citicoline, process and use |
10/11/2000 | EP1041987A1 Opioid agonist/antagonist combinations |
10/11/2000 | EP1041984A1 Pharmaceutical composition for oral administration |
10/11/2000 | EP1041981A2 $i(S)-PROCYCLIDINE FOR TREATING URINARY INCONTINENCE |
10/11/2000 | EP1041978A1 Methods of inactivating bacteria including bacterial spores |
10/11/2000 | EP1041976A1 Polyamide oligomers |
10/11/2000 | EP1041975A1 Rate controlling membranes for controlled drug delivery devices |
10/11/2000 | EP1041974A1 Beneficial agent delivery system with membrane plug |
10/11/2000 | EP1041973A2 Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution |
10/11/2000 | EP1041972A1 Tablet for instant and prolonged release of one or more active substances |
10/11/2000 | EP1041971A1 A method for making a pharmaceutical formulation |
10/11/2000 | EP1041970A1 Compositions of microspheres for wound healing |
10/11/2000 | EP1041969A2 Novel pharmaceutical compositions of uridine triphosphate |
10/11/2000 | EP1041968A1 Osmotic delivery system with membrane plug retention mechanism |
10/11/2000 | EP1041967A1 Microparticles and their therapeutic or diagnostic use |
10/11/2000 | EP1041966A2 Pharmaceutical compositions |
10/11/2000 | EP1041965A1 Tablet composition |
10/11/2000 | EP1041895A1 Animal feed pelleting process and animal feed pellets produced therefrom |
10/11/2000 | EP1041880A1 A delivery of arginine to cause beneficial effects |
10/11/2000 | EP0907725B1 A process for encapsulating viable animal cells |
10/11/2000 | EP0824916B1 Pranoprofen eyedrops containing organic amine |
10/11/2000 | EP0778768A4 Formulations and methods for providing prolonged local anesthesia |
10/11/2000 | EP0697860B1 Transdermal therapeutic system containing estradiol |
10/11/2000 | EP0625068B1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
10/11/2000 | CN2400112Y High molecular water plaster |
10/11/2000 | CN1269811A Polyanhydrides with therapeutically useful degradation properties |
10/11/2000 | CN1269729A Composition for releiving inflamation and product thereof |
10/11/2000 | CN1269728A Decreased fat absorption with anti-lipase antibody |
10/11/2000 | CN1269717A Therapeutical system for transdermal delivery of leconorgestrel |
10/11/2000 | CN1269716A Transdermal therapeutic system (TTS) for administrating sexual steroid hormones |
10/11/2000 | CN1269715A Method and composition for treating late allergic reactions and inflammation diseases |
10/11/2000 | CN1269377A Water soluble or water dispersant polymer salts |
10/11/2000 | CN1269235A Preparation of Guoyouling Babu plaster |
10/11/2000 | CN1269232A Pain-relieving cigarette and its making process |
10/11/2000 | CN1269221A Anticarcinogen injecta and its preparation |
10/11/2000 | CN1269217A Bagged blood circulation-activating and obstruction-dredging granule and its preparation |
10/11/2000 | CN1269216A Tendon injure treating spray and its preparation |
10/11/2000 | CN1269214A Thrombus dissolving capsule |
10/11/2000 | CN1269209A Double-layered buccal tablet of Chinese globeflower and vitamin C and its making process |
10/11/2000 | CN1269206A Making process of Babu plaster for rheumatism and ostealiga |
10/11/2000 | CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate |
10/11/2000 | CN1057230C Chinese medicine capsule for treating thrombophlebitis |
10/11/2000 | CN1057226C Oral liquor for giving-up drug-taking and preparation method |
10/11/2000 | CN1057220C Compound anti-cancer Chinese medicine |
10/11/2000 | CN1057215C Ointment for burns made of sausurea Involucrata |
10/11/2000 | CN1057214C Cooling throat oral liquor and preparation technology |
10/11/2000 | CN1057213C Chinese medicinal preparation for treating skin diseases |
10/11/2000 | CN1057212C Oral liquor for body-building |
10/11/2000 | CN1057211C Toxin-resolving plaster for curing carbuncle, furuncle etc. and preparation method |
10/11/2000 | CN1057210C Kuh-seng, large-flowered skullap roof and coptis root tablet and its preparing method |
10/10/2000 | US6130254 Methods for inhibiting photoaging of skin |
10/10/2000 | US6130249 Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate |
10/10/2000 | US6130242 S-procyclidine for treating urinary incontinence |
10/10/2000 | US6130213 Topical use |
10/10/2000 | US6130209 Cascading polymers |
10/10/2000 | US6130208 Formulation containing a nucleotide analogue |
10/10/2000 | US6130200 Gel composition and methods |
10/10/2000 | US6129944 Product containing a microcrystalline plant sterol, a sweetening agent and water; edible spread made of product and berry or fruit; lowering cholesterol by administering product |
10/10/2000 | US6129933 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
10/10/2000 | US6129932 Compositions for inhibiting platelet aggregation |
10/10/2000 | US6129931 Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone |
10/10/2000 | US6129930 Without causing treatment-limiting elevations in uric acid levels and/or glucose levels, by orally administering an antihyperlipidemic amount of niacin and an excipient to provide sustained release; fda orange book listed patent for niacin and simvastatin |
10/10/2000 | US6129929 Transdermal patch releasably affixed to a bottom release liner; and releasably affixed to the transdermal patch, a top release liner which has a tab that extends beyond the end of patch to ease removal of top liner and patch from bottom |
10/10/2000 | US6129926 Flash flow processing of thermoplastic polymers and products made therefrom |
10/10/2000 | US6129925 Container filled with infusion liquids and infusion preparation |
10/10/2000 | US6129916 Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates |
10/10/2000 | US6129906 Silicone containing powders |
10/10/2000 | US6129905 Aerosol formulations containing a sugar as a dispersant |
10/10/2000 | US6129141 Air conditioning/providing system directly through natural heat preserving main body |
10/10/2000 | CA2183415C A new skin preparation composition |
10/10/2000 | CA2147606C Stable extended release oral dosage composition |